C
Merck KGaA
MKKGY
$29.56
-$0.68-2.25%
C
Hold
3/6/2025Upgraded
Merck KGaA (MKKGY) was upgraded to C- from D+ on 3/6/2025 due to an increase in the dividend index, valuation index and efficiency index.
Merck KGaA (MKKGY) was upgraded to C- from D+ on 3/6/2025 due to an increase in the dividend index, valuation index and efficiency index.
D
Sell
2/10/2025Downgrade
Merck KGaA (MKKGY) was downgraded to D+ from C- on 2/10/2025 due to a decline in the total return index, volatility index and valuation index.
Merck KGaA (MKKGY) was downgraded to D+ from C- on 2/10/2025 due to a decline in the total return index, volatility index and valuation index.
C
Hold
12/20/2024Downgrade
Merck KGaA (MKKGY) was downgraded to C- from C on 12/20/2024 due to a decline in the total return index, volatility index and efficiency index.
Merck KGaA (MKKGY) was downgraded to C- from C on 12/20/2024 due to a decline in the total return index, volatility index and efficiency index.
C
Hold
11/4/2024Upgraded
Merck KGaA (MKKGY) was upgraded to C from C- on 11/4/2024 due to an increase in the valuation index.
Merck KGaA (MKKGY) was upgraded to C from C- on 11/4/2024 due to an increase in the valuation index.
C
Hold
9/23/2024Downgrade
Merck KGaA (MKKGY) was downgraded to C- from C on 9/23/2024 due to a decline in the volatility index.
Merck KGaA (MKKGY) was downgraded to C- from C on 9/23/2024 due to a decline in the volatility index.
C
Hold
8/19/2024Upgraded
Merck KGaA (MKKGY) was upgraded to C from C- on 8/19/2024 due to an increase in the total return index and volatility index.
Merck KGaA (MKKGY) was upgraded to C from C- on 8/19/2024 due to an increase in the total return index and volatility index.
C
Hold
8/2/2024Downgrade
Merck KGaA (MKKGY) was downgraded to C- from C on 8/2/2024 due to a major decline in the growth index, efficiency index and valuation index. Operating cash flow declined 17.52% from $1.12B to $926.73M, EBIT declined 15.55% from $1.01B to $853.53M, and net income declined 13.28% from $753.4M to $653.34M.
Merck KGaA (MKKGY) was downgraded to C- from C on 8/2/2024 due to a major decline in the growth index, efficiency index and valuation index. Operating cash flow declined 17.52% from $1.12B to $926.73M, EBIT declined 15.55% from $1.01B to $853.53M, and net income declined 13.28% from $753.4M to $653.34M.
C
Hold
7/26/2024Upgraded
Merck KGaA (MKKGY) was upgraded to C from C- on 7/26/2024 due to an increase in the volatility index and total return index.
Merck KGaA (MKKGY) was upgraded to C from C- on 7/26/2024 due to an increase in the volatility index and total return index.
C
Hold
7/5/2024Downgrade
Merck KGaA (MKKGY) was downgraded to C- from C on 7/5/2024 due to a decline in the dividend index, volatility index and efficiency index.
Merck KGaA (MKKGY) was downgraded to C- from C on 7/5/2024 due to a decline in the dividend index, volatility index and efficiency index.
C
Hold
3/8/2024Upgraded
Merck KGaA (MKKGY) was upgraded to C from C- on 3/8/2024 due to an increase in the dividend index, total return index and efficiency index.
Merck KGaA (MKKGY) was upgraded to C from C- on 3/8/2024 due to an increase in the dividend index, total return index and efficiency index.
C
Hold
3/7/2024Downgrade
Merck KGaA (MKKGY) was downgraded to C- from C on 3/7/2024 due to a decline in the volatility index and valuation index.
Merck KGaA (MKKGY) was downgraded to C- from C on 3/7/2024 due to a decline in the volatility index and valuation index.
C
Hold
2/20/2024Upgraded
Merck KGaA (MKKGY) was upgraded to C from C- on 2/20/2024 due to an increase in the volatility index.
Merck KGaA (MKKGY) was upgraded to C from C- on 2/20/2024 due to an increase in the volatility index.
C
Hold
2/2/2024Downgrade
Merck KGaA (MKKGY) was downgraded to C- from C on 2/2/2024 due to a noticeable decline in the total return index, growth index and volatility index. Total revenue declined 2.44% from $5.77B to $5.63B.
Merck KGaA (MKKGY) was downgraded to C- from C on 2/2/2024 due to a noticeable decline in the total return index, growth index and volatility index. Total revenue declined 2.44% from $5.77B to $5.63B.
C
Hold
6/20/2023Downgrade
Merck KGaA (MKKGY) was downgraded to C from C+ on 6/20/2023 due to a decline in the volatility index, total return index and valuation index.
Merck KGaA (MKKGY) was downgraded to C from C+ on 6/20/2023 due to a decline in the volatility index, total return index and valuation index.
C
Hold
5/24/2023Downgrade
Merck KGaA (MKKGY) was downgraded to C+ from B- on 5/24/2023 due to a decline in the total return index, dividend index and efficiency index.
Merck KGaA (MKKGY) was downgraded to C+ from B- on 5/24/2023 due to a decline in the total return index, dividend index and efficiency index.
B
Buy
3/6/2023Upgraded
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to B- from C+ on 3/6/2023 due to an increase in the dividend index, solvency index and total return index. The quick ratio increased from 0.72 to 0.75, and debt to equity declined from 0.38 to 0.37.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to B- from C+ on 3/6/2023 due to an increase in the dividend index, solvency index and total return index. The quick ratio increased from 0.72 to 0.75, and debt to equity declined from 0.38 to 0.37.
C
Hold
7/21/2022Downgrade
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to C+ from B- on 7/21/2022 due to a decline in the total return index, volatility index and valuation index.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to C+ from B- on 7/21/2022 due to a decline in the total return index, volatility index and valuation index.
B
Buy
7/6/2022Upgraded
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to B- from C+ on 7/6/2022 due to an increase in the volatility index, total return index and valuation index.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to B- from C+ on 7/6/2022 due to an increase in the volatility index, total return index and valuation index.
C
Hold
6/21/2022Downgrade
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to C+ from B- on 6/21/2022 due to a decline in the volatility index.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to C+ from B- on 6/21/2022 due to a decline in the volatility index.
B
Buy
5/13/2022Downgrade
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to B- from B on 5/13/2022 due to a noticeable decline in the volatility index, total return index and growth index. Operating cash flow declined 21.21% from $1.2B to $941.92M, EBIT declined 5.13% from $1.39B to $1.32B, and total revenue declined 2.26% from $5.96B to $5.83B.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to B- from B on 5/13/2022 due to a noticeable decline in the volatility index, total return index and growth index. Operating cash flow declined 21.21% from $1.2B to $941.92M, EBIT declined 5.13% from $1.39B to $1.32B, and total revenue declined 2.26% from $5.96B to $5.83B.
B
Buy
1/14/2022Downgrade
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to B from B+ on 1/14/2022 due to a major decline in the total return index, valuation index and volatility index.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to B from B+ on 1/14/2022 due to a major decline in the total return index, valuation index and volatility index.
B
Buy
8/9/2021Upgraded
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to B+ from B on 8/9/2021 due to a substantial increase in the total return index, growth index and volatility index. EBIT increased 9.45% from $1.26B to $1.38B, and total revenue increased 5.18% from $5.58B to $5.87B.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to B+ from B on 8/9/2021 due to a substantial increase in the total return index, growth index and volatility index. EBIT increased 9.45% from $1.26B to $1.38B, and total revenue increased 5.18% from $5.58B to $5.87B.
B
Buy
11/16/2020Upgraded
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to B from C+ on 11/16/2020 due to a significant increase in the growth index, total return index and valuation index. Earnings per share increased from $0.7381 to $2.1636, operating cash flow increased 147.44% from $552.99M to $1.37B, and EBIT increased 37.11% from $684.08M to $937.93M.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to B from C+ on 11/16/2020 due to a significant increase in the growth index, total return index and valuation index. Earnings per share increased from $0.7381 to $2.1636, operating cash flow increased 147.44% from $552.99M to $1.37B, and EBIT increased 37.11% from $684.08M to $937.93M.
C
Hold
11/2/2020Upgraded
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to C+ from C on 11/2/2020 due to an increase in the total return index, volatility index and solvency index.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to C+ from C on 11/2/2020 due to an increase in the total return index, volatility index and solvency index.
C
Hold
8/7/2020Downgrade
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to C from B- on 8/7/2020 due to a significant decline in the growth index, solvency index and valuation index. Earnings per share declined from $1.158 to $0.7381, EBIT declined 30.22% from $783.04M to $546.38M, and debt to equity increased from 0.72 to 0.77.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to C from B- on 8/7/2020 due to a significant decline in the growth index, solvency index and valuation index. Earnings per share declined from $1.158 to $0.7381, EBIT declined 30.22% from $783.04M to $546.38M, and debt to equity increased from 0.72 to 0.77.
B
Buy
7/24/2020Upgraded
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to B- from C+ on 7/24/2020 due to an increase in the total return index and volatility index.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to B- from C+ on 7/24/2020 due to an increase in the total return index and volatility index.
C
Hold
7/15/2020Upgraded
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to C+ from C on 7/15/2020 due to an increase in the volatility index and total return index.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to C+ from C on 7/15/2020 due to an increase in the volatility index and total return index.
C
Hold
5/26/2020Downgrade
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to C from C+ on 5/26/2020 due to a decline in the dividend index, volatility index and total return index.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to C from C+ on 5/26/2020 due to a decline in the dividend index, volatility index and total return index.
C
Hold
5/8/2020Downgrade
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to C+ from B- on 5/8/2020 due to a decline in the volatility index and total return index.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to C+ from B- on 5/8/2020 due to a decline in the volatility index and total return index.
B
Buy
3/16/2020Downgrade
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to B- from B on 3/16/2020 due to a significant decline in the growth index, valuation index and efficiency index. Operating cash flow declined 26.21% from $1.04B to $764.02M, earnings per share declined from $0.8786 to $0.808, and net income declined 7.69% from $381.46M to $352.11M.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to B- from B on 3/16/2020 due to a significant decline in the growth index, valuation index and efficiency index. Operating cash flow declined 26.21% from $1.04B to $764.02M, earnings per share declined from $0.8786 to $0.808, and net income declined 7.69% from $381.46M to $352.11M.
B
Buy
10/21/2019Upgraded
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to B from B- on 10/21/2019 due to an increase in the volatility index and total return index.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to B from B- on 10/21/2019 due to an increase in the volatility index and total return index.
B
Buy
9/25/2019Upgraded
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to B- from C+ on 9/25/2019 due to an increase in the total return index and volatility index.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to B- from C+ on 9/25/2019 due to an increase in the total return index and volatility index.
C
Hold
9/12/2019Upgraded
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to C+ from C on 9/12/2019 due to a significant increase in the growth index, volatility index and solvency index. Earnings per share increased from $0.4885 to $1.2136, operating cash flow increased 49.08% from $560.02M to $834.89M, and EBIT increased 48.74% from $464.6M to $691.06M.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to C+ from C on 9/12/2019 due to a significant increase in the growth index, volatility index and solvency index. Earnings per share increased from $0.4885 to $1.2136, operating cash flow increased 49.08% from $560.02M to $834.89M, and EBIT increased 48.74% from $464.6M to $691.06M.
C
Hold
7/9/2019Downgrade
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to C from C+ on 7/9/2019 due to a decline in the volatility index and total return index.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to C from C+ on 7/9/2019 due to a decline in the volatility index and total return index.
C
Hold
6/24/2019Upgraded
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to C+ from C on 6/24/2019 due to an increase in the volatility index.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to C+ from C on 6/24/2019 due to an increase in the volatility index.
C
Hold
6/7/2019Downgrade
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to C from C+ on 6/7/2019 due to a decline in the volatility index, total return index and solvency index.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to C from C+ on 6/7/2019 due to a decline in the volatility index, total return index and solvency index.
C
Hold
5/15/2019Downgrade
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to C+ from B- on 5/15/2019 due to a substantial decline in the growth index, dividend index and volatility index. Earnings per share declined from $6.4214 to $0.4885, operating cash flow declined 33.7% from $844.69M to $560.02M, and EBIT declined 29.21% from $656.34M to $464.6M.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to C+ from B- on 5/15/2019 due to a substantial decline in the growth index, dividend index and volatility index. Earnings per share declined from $6.4214 to $0.4885, operating cash flow declined 33.7% from $844.69M to $560.02M, and EBIT declined 29.21% from $656.34M to $464.6M.
B
Buy
5/7/2019Downgrade
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to B- from B on 5/7/2019 due to a decline in the volatility index and total return index.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to B- from B on 5/7/2019 due to a decline in the volatility index and total return index.
B
Buy
3/12/2019Upgraded
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to B from B- on 3/12/2019 due to a large increase in the growth index, dividend index and efficiency index. Earnings per share increased from $0.9071 to $6.4214, net income increased 606.16% from $395.38M to $2.79B, and EBIT increased 22.96% from $533.77M to $656.34M.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to B from B- on 3/12/2019 due to a large increase in the growth index, dividend index and efficiency index. Earnings per share increased from $0.9071 to $6.4214, net income increased 606.16% from $395.38M to $2.79B, and EBIT increased 22.96% from $533.77M to $656.34M.
B
Buy
3/7/2019Downgrade
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to B- from B on 3/7/2019 due to a decline in the volatility index.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to B- from B on 3/7/2019 due to a decline in the volatility index.
B
Buy
2/20/2019Upgraded
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to B from B- on 2/20/2019 due to an increase in the total return index and valuation index.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to B from B- on 2/20/2019 due to an increase in the total return index and valuation index.
B
Buy
11/30/2018Upgraded
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to B- from C on 11/30/2018 due to an increase in the total return index.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to B- from C on 11/30/2018 due to an increase in the total return index.
C
Hold
11/27/2018Downgrade
Merck KGaA (MKKGY) was downgraded to C from B- on 11/27/2018.
Merck KGaA (MKKGY) was downgraded to C from B- on 11/27/2018.
B
Buy
11/26/2018Upgraded
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to B- from C on 11/26/2018 due to an increase in the growth index, total return index and volatility index. Operating cash flow increased 94.21% from $437.7M to $850.07M, earnings per share increased from $0.6798 to $0.9071, and EBIT increased 2.65% from $519.99M to $533.77M.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to B- from C on 11/26/2018 due to an increase in the growth index, total return index and volatility index. Operating cash flow increased 94.21% from $437.7M to $850.07M, earnings per share increased from $0.6798 to $0.9071, and EBIT increased 2.65% from $519.99M to $533.77M.
C
Hold
10/18/2018Downgrade
Merck KGaA (MKKGY) was downgraded to C from C+ on 10/18/2018.
Merck KGaA (MKKGY) was downgraded to C from C+ on 10/18/2018.
C
Hold
9/21/2018Upgraded
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to C+ from C on 9/21/2018 due to a noticeable increase in the volatility index, efficiency index and valuation index. Total capital increased 0.02% from $30.68B to $30.68B.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to C+ from C on 9/21/2018 due to a noticeable increase in the volatility index, efficiency index and valuation index. Total capital increased 0.02% from $30.68B to $30.68B.
C
Hold
3/8/2018Downgrade
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to C from C+ on 3/8/2018 due to a noticeable decline in the volatility index and total return index.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to C from C+ on 3/8/2018 due to a noticeable decline in the volatility index and total return index.
C
Hold
2/1/2018Downgrade
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to C+ from B- on 2/1/2018 due to a decline in the volatility index, total return index and valuation index.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to C+ from B- on 2/1/2018 due to a decline in the volatility index, total return index and valuation index.
B
Buy
11/28/2017Downgrade
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to B- from B on 11/28/2017 due to a decline in the volatility index and total return index.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was downgraded to B- from B on 11/28/2017 due to a decline in the volatility index and total return index.
B
Buy
9/1/2017Upgraded
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to B from B- on 9/1/2017 due to an increase in the volatility index.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to B from B- on 9/1/2017 due to an increase in the volatility index.
B
Buy
8/15/2017Upgraded
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to B- from C on 8/15/2017 due to a significant increase in the valuation index, growth index and total return index. Total revenue increased 4.12% from $4.12B to $4.28B.
Merck Kommanditgesellschaft auf Aktien (MKKGY) was upgraded to B- from C on 8/15/2017 due to a significant increase in the valuation index, growth index and total return index. Total revenue increased 4.12% from $4.12B to $4.28B.
C
Hold
3/14/2016Upgraded
Merck KGaA (MKGAY) was upgraded to C from D on 3/14/2016 due to a significant increase in the efficiency index, growth index and dividend index.
Merck KGaA (MKGAY) was upgraded to C from D on 3/14/2016 due to a significant increase in the efficiency index, growth index and dividend index.
D
Sell
3/9/2016Downgrade
Merck KGaA (MKGAY) was downgraded to D from C+ on 3/9/2016 due to a significant decline in the efficiency index, growth index and solvency index. The quick ratio declined from 2.73 to 0.45, and debt to equity increased from 0.74 to 1.08.
Merck KGaA (MKGAY) was downgraded to D from C+ on 3/9/2016 due to a significant decline in the efficiency index, growth index and solvency index. The quick ratio declined from 2.73 to 0.45, and debt to equity increased from 0.74 to 1.08.
C
Hold
2/1/2016Downgrade
Merck KGaA (MKGAY) was downgraded to C+ from B- on 2/1/2016 due to a noticeable decline in the growth index, total return index and volatility index. Total revenue declined 2.62% from $3.56B to $3.47B.
Merck KGaA (MKGAY) was downgraded to C+ from B- on 2/1/2016 due to a noticeable decline in the growth index, total return index and volatility index. Total revenue declined 2.62% from $3.56B to $3.47B.
B
Buy
10/5/2015Downgrade
Merck KGaA (MKGAY) was downgraded to B- from B on 10/5/2015 due to a significant decline in the volatility index and total return index.
Merck KGaA (MKGAY) was downgraded to B- from B on 10/5/2015 due to a significant decline in the volatility index and total return index.
B
Buy
6/12/2015Downgrade
Merck KGaA (MKGAY) was downgraded to B from A- on 6/12/2015 due to a significant decline in the valuation index.
Merck KGaA (MKGAY) was downgraded to B from A- on 6/12/2015 due to a significant decline in the valuation index.
A
Buy
6/8/2015Downgrade
Merck KGaA (MKGAY) was downgraded to A- from A on 6/8/2015 due to a decline in the total return index and volatility index.
Merck KGaA (MKGAY) was downgraded to A- from A on 6/8/2015 due to a decline in the total return index and volatility index.
A
Buy
5/22/2015Upgraded
Merck KGaA (MKGAY) was upgraded to A from B on 5/22/2015 due to a significant increase in the growth index, valuation index and solvency index.
Merck KGaA (MKGAY) was upgraded to A from B on 5/22/2015 due to a significant increase in the growth index, valuation index and solvency index.
B
Buy
5/20/2015Downgrade
Merck KGaA (MKGAY) was downgraded to B from A on 5/20/2015 due to a significant decline in the growth index, valuation index and volatility index. Operating cash flow declined 78.02% from $1.43B to $313.37M, and total revenue declined 9.82% from $3.79B to $3.42B.
Merck KGaA (MKGAY) was downgraded to B from A on 5/20/2015 due to a significant decline in the growth index, valuation index and volatility index. Operating cash flow declined 78.02% from $1.43B to $313.37M, and total revenue declined 9.82% from $3.79B to $3.42B.
A
Buy
3/12/2015Upgraded
Merck KGaA (MKGAY) was upgraded to A from B on 3/12/2015 due to a significant increase in the growth index, valuation index and dividend index.
Merck KGaA (MKGAY) was upgraded to A from B on 3/12/2015 due to a significant increase in the growth index, valuation index and dividend index.
B
Buy
3/4/2015Downgrade
Merck KGaA (MKGAY) was downgraded to B from A on 3/4/2015 due to a significant decline in the growth index, valuation index and solvency index. EBIT declined 49.19% from $665.82M to $338.31M, debt to equity increased from 0.37 to 0.5, and total revenue declined 2.5% from $3.89B to $3.79B.
Merck KGaA (MKGAY) was downgraded to B from A on 3/4/2015 due to a significant decline in the growth index, valuation index and solvency index. EBIT declined 49.19% from $665.82M to $338.31M, debt to equity increased from 0.37 to 0.5, and total revenue declined 2.5% from $3.89B to $3.79B.
A
Buy
1/29/2015Upgraded
Merck KGaA (MKGAY) was upgraded to A from A- on 1/29/2015 due to an increase in the total return index and volatility index.
Merck KGaA (MKGAY) was upgraded to A from A- on 1/29/2015 due to an increase in the total return index and volatility index.
A
Buy
1/2/2015Downgrade
Merck KGaA (MKGAY) was downgraded to A- from A on 1/2/2015 due to a decline in the total return index.
Merck KGaA (MKGAY) was downgraded to A- from A on 1/2/2015 due to a decline in the total return index.
A
Buy
12/17/2014Upgraded
Merck KGaA (MKGAY) was upgraded to A from A- on 12/17/2014 due to a noticeable increase in the total return index and volatility index.
Merck KGaA (MKGAY) was upgraded to A from A- on 12/17/2014 due to a noticeable increase in the total return index and volatility index.
A
Buy
11/12/2014Downgrade
Merck KGaA (MKGAY) was downgraded to A- from A on 11/12/2014 due to a decline in the volatility index and valuation index.
Merck KGaA (MKGAY) was downgraded to A- from A on 11/12/2014 due to a decline in the volatility index and valuation index.
A
Buy
10/28/2014Upgraded
Merck KGaA (MKGAY) was upgraded to A from A- on 10/28/2014 due to an increase in the volatility index and valuation index.
Merck KGaA (MKGAY) was upgraded to A from A- on 10/28/2014 due to an increase in the volatility index and valuation index.
A
Buy
10/13/2014Downgrade
Merck KGaA (MKGAY) was downgraded to A- from A on 10/13/2014 due to a decline in the volatility index and total return index.
Merck KGaA (MKGAY) was downgraded to A- from A on 10/13/2014 due to a decline in the volatility index and total return index.
A
Buy
9/26/2014Upgraded
Merck KGaA (MKGAY) was upgraded to A from A- on 9/26/2014 due to an increase in the growth index, efficiency index and volatility index. Total revenue increased 7.51% from $3.65B to $3.93B, operating cash flow increased 5.13% from $560.15M to $588.9M, and total capital increased 1.12% from $20.63B to $20.86B.
Merck KGaA (MKGAY) was upgraded to A from A- on 9/26/2014 due to an increase in the growth index, efficiency index and volatility index. Total revenue increased 7.51% from $3.65B to $3.93B, operating cash flow increased 5.13% from $560.15M to $588.9M, and total capital increased 1.12% from $20.63B to $20.86B.
A
Buy
8/4/2014Downgrade
Merck KGaA (MKGAY) was downgraded to A- from A on 8/4/2014 due to a decline in the volatility index.
Merck KGaA (MKGAY) was downgraded to A- from A on 8/4/2014 due to a decline in the volatility index.
A
Buy
7/15/2014Upgraded
Merck KGaA (MKGAY) was upgraded to A from A- on 7/15/2014 due to an increase in the total return index.
Merck KGaA (MKGAY) was upgraded to A from A- on 7/15/2014 due to an increase in the total return index.
A
Buy
7/11/2014None
Merck KGaA (MKKGY) was downgraded to A- from U on 07/11/2014.
Merck KGaA (MKKGY) was downgraded to A- from U on 07/11/2014.
OTC PK
03/07/2025 3:59PM Eastern
Quotes delayed
